SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SuanFarma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10803
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated tablet, and summum propol, among others. It also provides ironkit, generics services, OTC, baby food, veterinary, plameca, APIs, oncosuan, cidqo, dermotological products; and biotech and development and manufacturing services. SuanFarma Group offers drug development and manufacturing services such as analytical development, stabilities, galenic development, formulation and pilot batches, among others. The company caters to biotechnological, veterinary, pharmaceutical, nutritional and cosmetic sectors. SuanFarma Group is headquartered in Alcobendas, Spain.

SuanFarma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SuanFarma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SuanFarma SA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Intermediate Capital Group Acquires SuanFarma from ProA Capital 10
Equity Offering 11
Idifarma Desarrollo Farmaceutico Secures Investment from Suanfarma 11
Acquisition 12
Lusosuan Acquires 4.76% Stake in CIPAN 12
Suanfarma Acquires CIPAN 13
SuanFarma SA – Key Competitors 14
SuanFarma SA – Key Employees 15
SuanFarma SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SuanFarma SA, Pharmaceuticals & Healthcare, Key Facts 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Deals By Therapy Area, 2012 to YTD 2018 8
SuanFarma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intermediate Capital Group Acquires SuanFarma from ProA Capital 10
Idifarma Desarrollo Farmaceutico Secures Investment from Suanfarma 11
Lusosuan Acquires 4.76% Stake in CIPAN 12
Suanfarma Acquires CIPAN 13
SuanFarma SA, Key Competitors 14
SuanFarma SA, Key Employees 15
SuanFarma SA, Other Locations 16
SuanFarma SA, Subsidiaries 16

List of Figures
SuanFarma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • INTL FCStone Inc:企業の戦略・SWOT・財務情報
    INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report Summary INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sembcorp Industries Ltd (U96)-石油・ガス分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Torii Pharmaceutical Co Ltd (4551)-製薬・医療分野:企業M&A・提携分析
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …
  • Koln Dusseldorfer Deutsche Rheinschiffahrt Ag
    Koln Dusseldorfer Deutsche Rheinschiffahrt Ag - Strategy, SWOT and Corporate Finance Report Summary Koln Dusseldorfer Deutsche Rheinschiffahrt Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polyme …
  • W.H. Brakspear & Sons Limited:企業の戦略・SWOT・財務情報
    W.H. Brakspear & Sons Limited - Strategy, SWOT and Corporate Finance Report Summary W.H. Brakspear & Sons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AIT Austrian Institute of Technology GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AIT Austrian Institute of Technology GmbH (AIT) is a research and technology organisation which provides research and development services. The institute provides research and technological development for infrastructure related technologies in the fields of energy, mobility systems, low-emi …
  • Econocom Group SA (ECONB):企業の財務・戦略的SWOT分析
    Econocom Group SA (ECONB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Boeing Defence Australia Limited:企業の戦略・SWOT・財務情報
    Boeing Defence Australia Limited - Strategy, SWOT and Corporate Finance Report Summary Boeing Defence Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務情報
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Kracie Holdings, Ltd.:企業の戦略・SWOT・財務情報
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Saertex GmbH & Co KG:企業の戦略的SWOT分析
    Saertex GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • International Fibres Group Ltd:企業の戦略的SWOT分析
    International Fibres Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Beacon Roofing Supply Inc:企業の戦略・SWOT・財務分析
    Beacon Roofing Supply Inc - Strategy, SWOT and Corporate Finance Report Summary Beacon Roofing Supply Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Italiaonline SpA:企業の戦略的SWOT分析
    Italiaonline SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bangkok Bank Public Co Ltd:企業のM&A・事業提携・投資動向
    Bangkok Bank Public Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bangkok Bank Public Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報
    Summary Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostat …
  • Seoul National University Hospital:企業の戦略的SWOT分析
    Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆